Theravectys develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions. Founded in 2005, Theravectys is backed by investors that include Bpifrance, Tethys BioScience, Philippe ODDO, Guy PAILLAUD, and John PIETERS and is headquartered in Paris.
FOUNDED:
2005
INDUSTRY:
Biopharma, Biotechnology, Health Care
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
